HIGHLIGHTS
- who: Shaoqiu Liu et al. from the Department of Obstetrics and Gynecology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China have published the research: Overexpression of RIPK4 Predicts Poor Prognosis and Promotes Metastasis in Ovarian Cancer, in the Journal: BioMed Research International 1.0 of 20/Dec/2020
- what: This study was conducted to evaluate the prognostic value of receptor-interacting protein kinase 4 (RIPK4) in ovarian cancer (OC) and its role in tumorigenesis. The aim of this study was to determine the prognostic value of RIPK4 expression in patients with . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.